# BugSigDB 2024-10-10_20:13_UTC, License: Creative Commons Attribution 4.0 International, URL: https://bugsigdb.org
bsdb:1/1/1_Colorectal-adenoma:conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	1301	162289	189330	33024	40544	1386
bsdb:1/1/2_Colorectal-adenoma:conventional-adenoma-cases_vs_controls_DOWN	NA	100883
bsdb:2/1/1_Head-and-neck-squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_UP	NA	543311
bsdb:2/1/2_Head-and-neck-squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_DOWN	NA	1654
bsdb:3/1/1_Colorectal-cancer:adenocarcinoma-of-colon-and-rectum-patients_vs_controls_UP	NA	848	836
bsdb:4/1/1_Hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_UP	NA	469	838	29465	33024
bsdb:4/1/2_Hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_DOWN	NA	375288	1263	574697	1678	53246	39948
bsdb:5/1/1_Chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_UP	NA	46123	1654	642	653683	1380	1678	118747	830	194	1016	43996	82202	84162	893	39948	156973	1730	848	52228	32067	186650	1839	133925	265975	543311	1257	838	32207	970	613	123375	1301	195950	29465
bsdb:5/1/2_Chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_DOWN	NA	1485	88138	2023	544	1663
bsdb:7/1/1_Autism:severely-autistic_vs_non-sibling-control_UP	NA	191303	816	286729	872	258514	375288
bsdb:7/1/2_Autism:severely-autistic_vs_non-sibling-control_DOWN	NA	114627	52784	109326	1678	1485	102106	39948	253238	31983	1578	1243	113286	1263	1301	46255
bsdb:10/1/1_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	437755
bsdb:14/1/1_Halitosis:Oral-Halitosis_vs_Control_UP	NA	194	195950	39948	1257	970	32067	2740	543311	157	1016	416916	838
bsdb:14/1/2_Halitosis:Oral-Halitosis_vs_Control_DOWN	NA	416916	724	437755	265975	838	1301	2740	32067
bsdb:15/1/1_Gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_UP	NA	33057
bsdb:15/1/2_Gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_DOWN	NA	55080	935200	1578	231454	44675
bsdb:16/1/1_Obesity:high-fat-diet_vs_normal-chow-diet_UP	NA	31980	1263	248744	239759	572511
bsdb:16/1/2_Obesity:high-fat-diet_vs_normal-chow-diet_DOWN	NA	816	283168	109326	574697	209	990721	35832	459786
bsdb:17/1/1_Anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	848	816	946234	1432051	1505663
bsdb:17/1/2_Anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	35832	580596	39948	216851	28050	46205	841	292632	40544
bsdb:18/1/1_Obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_UP	NA	244127	816	572511	830	1485	189330	1730	216851	1578	459786	1017280	841	1263	292632
bsdb:18/1/2_Obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_DOWN	NA	239934	239759	283168	375288	838	195950
bsdb:19/1/1_Schizophrenia:Schizophrenia_vs_Healthy-controls_UP	NA	838	83770	848	906	1578	544	33024	904	872
bsdb:19/1/2_Schizophrenia:Schizophrenia_vs_Healthy-controls_DOWN	NA	1301	33042	841	572511
bsdb:20/1/1_Non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_UP	NA	816
bsdb:20/1/2_Non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_DOWN	NA	838
bsdb:21/1/1_Obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_UP	NA	838	102106	841	1301	39948
bsdb:21/1/2_Obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_DOWN	NA	816	375288	239759
bsdb:22/1/1_Parkinson's-disease:Parkinson's_vs_Healthy-controls_UP	NA	1578	990721	270497	119852	1678
bsdb:22/1/2_Parkinson's-disease:Parkinson's_vs_Healthy-controls_DOWN	NA	189330	816	838	216851
bsdb:23/1/1_Alzheimer's-disease:Alzheimer's_vs_Healhty-controls_UP	NA	239759	816	572511	1378	33024	35832
bsdb:23/1/2_Alzheimer's-disease:Alzheimer's_vs_Healhty-controls_DOWN	NA	447020	1678	1485	39948	86331
bsdb:24/1/1_Chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_UP	NA	331654	816	194	848	1378
bsdb:24/1/2_Chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_DOWN	NA	29465	724	836	475	286
bsdb:25/1/1_Psoriasis:Psoriasis-Male_vs_Female_UP	NA	1301	150022	165779	29465	360541	1716	43668	32207	33882	57495	1016	469	36739	171412
bsdb:25/1/2_Psoriasis:Psoriasis-Male_vs_Female_DOWN	NA	1578	1743	2701	212791	1696
bsdb:26/1/1_Sex-design:female_vs_male_UP	NA	35832
bsdb:27/1/1_Obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_UP	NA	1485	191303	2740	946234	574697	580596	375288
bsdb:27/1/2_Obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_DOWN	NA	816	239759	397864	209	283168	872	174708	28138	1331051
bsdb:28/1/1_Chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_UP	NA	119852	84111	1357	244127	100883
bsdb:28/1/2_Chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_DOWN	NA	2740	724	1380	1485	216851	1263	416916	1678	102106	40544
bsdb:29/1/1_Unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	946234	574697	375288	239759
bsdb:29/1/2_Unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	216851	39948	1263	724	561	620
bsdb:31/1/1_Chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_UP	NA	207244	1485	100883	1017280
bsdb:31/1/2_Chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_DOWN	NA	33042	189330	216851	1378	724	841
bsdb:38/1/1_Body-odor-measurement:head-of-teenager_vs_head-of-child_UP	NA	1912216
bsdb:38/1/2_Body-odor-measurement:head-of-teenager_vs_head-of-child_DOWN	NA	55193	1279
bsdb:40/1/1_Attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_UP	NA	1678	84111	283168	375288	239759
bsdb:40/1/2_Attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_DOWN	NA	292632	1263	35829	33042
bsdb:42/1/1_Extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_UP	NA	1301	1350	1279	906	28100	158846
bsdb:42/1/2_Extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_DOWN	NA	1678	816	572511	216851	841	207244	102106
bsdb:47/1/1_Obesity:low_vs_high-dietary-fiber_UP	NA	1263
bsdb:49/1/1_Obesity:Obesity-group_vs_controls_UP	NA	43996	117563	86331	1257	838	123375
bsdb:49/1/2_Obesity:Obesity-group_vs_controls_DOWN	NA	724	2717	1016	47670	1716	1279	40323
bsdb:51/1/1_Colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_UP	NA	1578	838	150022	48736	1380	404402	1283313	1716	135858	1573535	543311	286	1378	1257	836	46255	117563	1654
bsdb:51/1/2_Colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_DOWN	NA	32067	196082	1678	33882	1847725	1573534	40544	28050	1506577	570
bsdb:52/1/1_Substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_UP	NA	838	265	1485	33057
bsdb:52/1/2_Substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_DOWN	NA	35832	189330	375288	1301	207244	906	1407607	239759	204475	816	1263
bsdb:55/1/1_Stimulus-or-stress-design:grid-floor-induced-stress_vs_control_UP	NA	283168	239759
bsdb:56/1/1_Type-II-diabetes-mellitus:Healthy-baby-meconium_vs_adult-stool_UP	NA	283	561	570	583	620
bsdb:60/1/1_Type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_UP	NA	458839	111142	504481	255204
bsdb:60/1/2_Type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_DOWN	NA	92793	338	1847
bsdb:64/1/2_Periodontitis:periodontitis_vs_No-Periodontitis-within-negative-diabetic-background-only_DOWN	NA	416916	32067
bsdb:65/1/1_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_UP	NA	416916	482	1378	538	1654	1016	848	29465	1301	970
bsdb:65/1/2_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_DOWN	NA	1730	44259	836	195950	157
bsdb:66/1/1_Neonatal-jaundice:cesarean-infants-with-jaundice_vs_control_UP	NA	106589
bsdb:68/1/1_Obesity:obese_vs_normal-weight_UP	NA	35832	572511	1485	33042	140625	1578	1263	1301
bsdb:68/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	1485	33042	51514	189330	119852	375288
bsdb:70/1/1_Obesity:pediatric-obese_vs_pediatric-normal-weight_UP	NA	39948	816	838
bsdb:70/1/2_Obesity:pediatric-obese_vs_pediatric-normal-weight_DOWN	NA	207244	40544	816
bsdb:71/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	1243	909928	2737	830
bsdb:72/1/2_Autism:autism_vs_typically-developing-controls_DOWN	NA	1301	29465	561	1654	543311	118747	162289
bsdb:76/1/1_Type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_UP	NA	572511	904
bsdb:76/1/2_Type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_DOWN	NA	39948	724	1392389
bsdb:77/1/2_Bipolar-disorder:atypical-antipsychotic-users_vs_non-users_DOWN	NA	239934
bsdb:78/1/1_Stimulus-or-stress-design:limited-nesting-stress_vs_controls_UP	NA	1350	1301	2740	1375	227979	66831	1485	1716	872	117563	32207	583	100883	1357	191303	2316
bsdb:78/1/2_Stimulus-or-stress-design:limited-nesting-stress_vs_controls_DOWN	NA	1263	841	33042	1573535	1279	375288	28050	244127	724	283168
bsdb:80/1/1_Type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_UP	NA	816
bsdb:80/1/2_Type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_DOWN	NA	838	904	158846
bsdb:83/1/1_Obesity:before-surgery_vs_after-surgery_UP	NA	207244	33042	216851	209	5782	40637
bsdb:83/1/2_Obesity:before-surgery_vs_after-surgery_DOWN	NA	544	547	590	29465	5140
bsdb:85/1/1_Cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	570	1266
bsdb:86/1/1_Cesarean-section:c-section_vs_vaginal-delivery-at-day-3_UP	NA	1279	1578
bsdb:90/1/1_Cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_UP	NA	209
bsdb:90/1/2_Cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_DOWN	NA	469	70774	1301	13687	1716	42255	165695	129337	482	165779	407	29465	1269	1357	357	212791	29580	80865
bsdb:91/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	1386	1298	1730	216851	40323
bsdb:91/1/2_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1743	283	286
bsdb:95/1/1_Obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_UP	NA	189330	841
bsdb:95/1/2_Obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_DOWN	NA	375288
bsdb:96/1/1_Obesity:obese_vs_controls_UP	NA	239759	165779	33042	848	543311
bsdb:96/1/2_Obesity:obese_vs_controls_DOWN	NA	816	872	216851	150022	1164882	133925	292632
bsdb:98/1/1_Chronic-kidney-disease:CKD_vs_controls_UP	NA	469	1386	81	445	68	1664383	286	504481	613	629
bsdb:98/1/2_Chronic-kidney-disease:CKD_vs_controls_DOWN	NA	1705353	911113	1716	1210119	265	13687	40323	1506577
bsdb:100/1/1_Obesity:High-BMI_vs_low-BMI_UP	NA	613	838
bsdb:102/1/1_Type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_UP	NA	838	1263
bsdb:102/1/2_Type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_DOWN	NA	572511	239759
bsdb:103/1/1_Unipolar-depression:depressed-female_vs_Healthy-Controls_UP	NA	572511	1654	1678	553372	1380	84111	644652	133925	1730	207244	841	216851	872
bsdb:103/1/2_Unipolar-depression:depressed-female_vs_Healthy-Controls_DOWN	NA	404402	40544	638847
bsdb:104/1/1_Unipolar-depression:major-depressive-disorder-(visit-1)_vs_healthy-controls_UP	NA	838	570	1301
bsdb:105/1/1_Bipolar-disorder:Bipolar_vs_Healthy-controls_DOWN	NA	216851
bsdb:106/1/1_Bipolar-disorder:bipolar-disorder-patients_vs_healthy-controls_UP	NA	946234
bsdb:107/1/2_Anorexia-nervosa:Anorexia-patients-at-T1_vs_Healthy-comparison-group-(HCG)_DOWN	NA	207244	216851
bsdb:109/1/1_Anorexia-nervosa:anorexia-patients-before-weight-gain_vs_normal-weight-participants_UP	NA	207244	244127	1678	1485
bsdb:109/1/2_Anorexia-nervosa:anorexia-patients-before-weight-gain_vs_normal-weight-participants_DOWN	NA	204475	841
bsdb:111/1/1_Attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_UP	NA	469	990721	100883	1573534	1473205	40323	1505652
bsdb:111/1/2_Attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_DOWN	NA	39948	1506553	216851	40544	904	1508657	1506577
bsdb:112/1/1_Attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_UP	NA	482	816
bsdb:112/1/2_Attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_DOWN	NA	838	375288
bsdb:113/1/1_Unipolar-depression:MDD_vs_controls_DOWN	NA	1678
bsdb:114/1/1_Unipolar-depression:MDD_vs_controls_UP	NA	846	543311	118747	286	1257	1378
bsdb:114/1/2_Unipolar-depression:MDD_vs_controls_DOWN	NA	216851	33042	572511	189330
bsdb:122/1/1_Breast-carcinoma:tumor-tissue_vs_normal-tissue_UP	NA	237	407
bsdb:122/1/2_Breast-carcinoma:tumor-tissue_vs_normal-tissue_DOWN	NA	13687	914	374
bsdb:126/1/1_Oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_UP	NA	724	1386
bsdb:126/1/2_Oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_DOWN	NA	1301	46123
bsdb:127/1/1_Alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	1485	61170	40544
bsdb:127/1/2_Alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	216851
bsdb:131/1/1_Diet:Time-7-days_vs_Time-0-days-controls_DOWN	NA	119852
bsdb:134/1/1_Diet:6-months-after-Average-Danish-Diet_vs_before-Average-Danish-Diet_UP	NA	872
bsdb:135/1/1_Diet:High-animal-protein_vs_low-animal-protein_UP	NA	816
bsdb:137/1/1_Colorectal-cancer:CRC_vs_controls_UP	NA	642	848
bsdb:137/1/2_Colorectal-cancer:CRC_vs_controls_DOWN	NA	816	35832	544	413496	189330	1730	841
bsdb:139/1/2_Head-and-neck-squamous-cell-carcinoma:HNSCC_vs_controls_DOWN	NA	1716	32257
bsdb:140/1/1_Multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_UP	NA	2172	239934	84593
bsdb:140/1/2_Multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_DOWN	NA	574697
bsdb:144/1/1_Air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_UP	NA	32207	265975	482	1654
bsdb:144/1/2_Air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_DOWN	NA	848	475	1257	836	838	29465
bsdb:146/1/1_Oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_UP	NA	2093	157	194	538	82202	1283313	848	970	39948	1257	44259	2740	43996	543311	1016
bsdb:146/1/2_Oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_DOWN	NA	906	1213720	117563	47670	29465	1301	196081	32207	1654
bsdb:147/1/1_Squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_UP	NA	848	838	543311	1257	39948	43996	970	157	32008
bsdb:147/1/2_Squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_DOWN	NA	1301	32207
bsdb:148/1/1_Polycystic-ovary-syndrome:NIR-PCOS---NIR(Non-Insulin-Resistance)_vs_HC---Healthy-Controls_UP	NA	816	28050
bsdb:148/1/2_Polycystic-ovary-syndrome:NIR-PCOS---NIR(Non-Insulin-Resistance)_vs_HC---Healthy-Controls_DOWN	NA	838
bsdb:152/1/1_Cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	189330	581	583	1263	22	83770
bsdb:152/1/2_Cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	2745	33024
bsdb:153/1/1_Prostate-cancer:prostate-cancer_vs_non-prostate-cancer_UP	NA	2747	129337	1357	1301
bsdb:153/1/2_Prostate-cancer:prostate-cancer_vs_non-prostate-cancer_DOWN	NA	114627	413496	1350	44249
bsdb:154/1/1_Colorectal-cancer:colorectal-cancer_vs_healthy-controls_UP	NA	46913	44249	59732
bsdb:154/1/2_Colorectal-cancer:colorectal-cancer_vs_healthy-controls_DOWN	NA	838	1730	570	32067	33024	86331	613
bsdb:156/1/1_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	838	561	620	570	1578	1301	239759	29465	1678	990721	375288
bsdb:156/1/2_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	216851	841	28050	1506553
bsdb:158/1/1_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_UP	NA	816	29465	848	33024
bsdb:158/1/2_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_DOWN	NA	579	216851	547	39948	561	620
bsdb:159/1/1_Gingival-disease:1-month-after-the-placement-of-the-brackets_vs_before_UP	NA	713	1016
bsdb:160/1/1_Head-and-neck-carcinoma:OCC-&-OPC_vs_High-risk-individuals_DOWN	NA	346096	1716	836	1654	713	1016	848	416916	47670
bsdb:165/1/1_Chronic-kidney-disease:chronic-kidney-disease-patients_vs_healthy-controls_UP	NA	1283313	1485	872	407	577309
bsdb:165/1/2_Chronic-kidney-disease:chronic-kidney-disease-patients_vs_healthy-controls_DOWN	NA	239934	174708	580024	1730	209	1578	1357	1243	248038	133925	265975	577310	1427376	638847	32207	2753
bsdb:166/1/1_Chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_UP	NA	816	84111	1505663	561	946234	375288	1508657	1769710	620	46255
bsdb:166/1/2_Chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_DOWN	NA	1506577	102106	580596	1501226	1263	841	33042	292632	28050	2747	39948
bsdb:167/1/1_Squamous-cell-carcinoma:Stage-4_vs_healthy-controls_UP	NA	82202
bsdb:169/1/1_Gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_UP	NA	47670	50729
bsdb:169/1/2_Gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	1213720
bsdb:170/1/1_Lung-cancer:cancerous-site_vs_controls_UP	NA	1301
bsdb:170/1/2_Lung-cancer:cancerous-site_vs_controls_DOWN	NA	1279
bsdb:171/1/1_Digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_UP	NA	1716	848	482	29465
bsdb:171/1/2_Digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_DOWN	NA	836	838	32207
bsdb:172/1/1_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	85413	80865	88	86331	32207
bsdb:172/1/2_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	59735	1016	848	836
bsdb:173/1/1_Pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_UP	NA	904	416916	194	135858	82202	413496	547	52228	570	1578	32067	200903	838	970	29465
bsdb:173/1/2_Pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_DOWN	NA	239934	239759	207244	244127	1678	35832	572511	41275	580596	1485	33042	189330	84111	946234	204475	158846	906	86331	651554	577310	583	379	44748
bsdb:176/1/1_Leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_UP	NA	1716	162289	150022	1279	1654
bsdb:176/1/2_Leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_DOWN	NA	216851	1263	28050
bsdb:177/1/1_Colorectal-cancer:colon-cancer-patients_vs_control-group_UP	NA	35832	1485	39948	848	2172	119852	1257
bsdb:177/1/2_Colorectal-cancer:colon-cancer-patients_vs_control-group_DOWN	NA	1301
bsdb:178/1/1_Gastric-cancer:gastric-cancer-peritumor-group_vs_normal_UP	NA	2745	22	1350	41275	1663	1763
bsdb:178/1/2_Gastric-cancer:gastric-cancer-peritumor-group_vs_normal_DOWN	NA	106589	445
bsdb:185/1/1_Gastric-cancer:gastric-cancer_vs_controls_UP	NA	561	620	1485	29465
bsdb:185/1/2_Gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	816
bsdb:187/1/1_Medroxyprogesterone-acetate:naive-black-participants-(baseline-visit)_vs_depot-medroxyprogesterone-acetate-vaginal-microbiome-(visit-2)-among-black-participants_UP	NA	838
bsdb:188/1/1_Cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_UP	NA	2701
bsdb:189/1/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_UP	NA	158846	1654
bsdb:189/1/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_DOWN	NA	816	574697	375288	553372	239759	1263
bsdb:194/1/1_Ovarian-cancer:ovarian-cancer_vs_normal-tissue_UP	NA	212791	283	1279	165695	407	106589	586	196013	504481	12916	13687	469
bsdb:194/1/2_Ovarian-cancer:ovarian-cancer_vs_normal-tissue_DOWN	NA	236752	1357
bsdb:196/1/1_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_UP	NA	29465	1350	158846	375288
bsdb:196/1/2_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_DOWN	NA	39948	724	570	28050	577310	841	1508657	1263	1301
bsdb:197/1/1_Asthma:severe-asthma_vs_non-asthma_UP	NA	239759	207244	816	1016	1432051	1730	216851	946234	5277	283168	459786	375288	4753	5533	1501226	841	1263
bsdb:197/1/2_Asthma:severe-asthma_vs_non-asthma_DOWN	NA	5206	237557	583	5615
bsdb:198/1/1_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_UP	NA	482	29465	838
bsdb:198/1/2_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_DOWN	NA	724	469
bsdb:200/1/2_Postmenopausal:Post-menopausal-patients_vs_Pre-menopausal-patients_UP	NA	1380	816	572511	194	1485	39948	216851	162290	33983	2740	162289	836	285105	72763	184869	165779	419014	1654	437755
bsdb:201/1/1_Leukemia:induction_vs_repeat-therapy_UP	NA	816	216851	459786	375288	1263
bsdb:201/1/2_Leukemia:induction_vs_repeat-therapy_DOWN	NA	1654	84111	1350	1573536	1578	292632	29465
bsdb:202/1/1_Autism:children-with-autism-mental-regression-(AMR)_vs_children-with-autism-non-mental-regression-(ANMR)_UP	NA	1350
bsdb:204/1/1_Premature-birth:mothers-whose-newborns-were-delivered-at-<34-gestational-week_vs_mothers-whose-newborns-were-delivered-at-≥37-getastional-weeks_DOWN	NA	1678
bsdb:207/1/1_Vulvovaginitis:Women-with-BV_vs_Normal-controls_UP	NA	1380	118747	39948	2701	2050	836	168808
bsdb:207/1/2_Vulvovaginitis:Women-with-BV_vs_Normal-controls_DOWN	NA	1578
bsdb:208/1/1_Food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	207244	1485	1350	216851	946234	1578	838	1279
bsdb:208/1/2_Food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	816	572511	158846	906	1301	29465
bsdb:210/1/1_Food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	239934	1678	102106	1350	216851	1578	841	1263	13687	292632	40544
bsdb:210/1/2_Food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	239759	816	375288	838	1301	29465
bsdb:211/1/1_Anemia:gestational-anemia-(GA1-group)_vs_healthy-controls(HC1-group)_UP	NA	244127	265975	543311	191303
bsdb:212/1/1_Diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	1654	283168	119852
bsdb:212/1/2_Diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	216851	28050
bsdb:214/1/1_Milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	547	590	158851
bsdb:214/1/2_Milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	572511	1730	1263
bsdb:215/1/1_Eczema:infants-with-eczema_vs_healthy-control-infants_UP	NA	239934	207244	35832	33042	872	547	216851	946234	204475	44249	375288	577309	33024	836	379	841	29465	561	620	1485
bsdb:215/1/2_Eczema:infants-with-eczema_vs_healthy-control-infants_DOWN	NA	904	209879	156454	244127	1678	43668	1696	580596	1485	102106	1716	39948	189330	538	117563	724	570	1578	906	459786	838	1263	1301	40544	191303
bsdb:216/1/1_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1380	1350
bsdb:218/1/1_Hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-controls_UP	NA	244127
bsdb:218/1/2_Hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-controls_DOWN	NA	28050	158846
bsdb:221/1/1_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_UP	NA	547
bsdb:221/1/2_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_DOWN	NA	39948	150022	724	149698
bsdb:223/1/1_HIV-infection:HIV-infected-patients_vs_healthy-controls_UP	NA	1350	1506553	1578	1301
bsdb:223/1/2_HIV-infection:HIV-infected-patients_vs_healthy-controls_DOWN	NA	816	39948	216851	158846	33024	838	292632
bsdb:224/1/1_Diet:barley-(WGB)_vs_baseline_UP	NA	572511
bsdb:224/1/2_Diet:barley-(WGB)_vs_baseline_DOWN	NA	283168	841	39948
bsdb:225/1/1_Atopic-eczema:infant-with-atopic-eczema_vs_healthy-infant_UP	NA	1350
bsdb:226/1/1_HIV-infection:HIV-1-infected-patients_vs_healthy-controls_UP	NA	580596	135858	189330	547	1350	216851	158846	577310	838
bsdb:226/1/2_HIV-infection:HIV-1-infected-patients_vs_healthy-controls_DOWN	NA	33042	397864	39948	816
bsdb:227/1/2_Atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	1678	239934
bsdb:228/1/1_Diet:day-3-of-PECTIN-spike-in_vs_day-6-of-PECTIN-spike-in_DOWN	NA	841	816	44748
bsdb:229/1/1_Diet:early-pectin-incubation-time_vs_late-pectin-incubation-time_UP	NA	1678	100883	846	283168	33042	574697	1263	207244	572511	375288	33024	841	816
bsdb:229/1/2_Diet:early-pectin-incubation-time_vs_late-pectin-incubation-time_DOWN	NA	28050	40544	189330	1485
bsdb:230/1/1_Food-allergy:infant-with-food-allergy_vs_non-allergy_DOWN	NA	1243	46255	29465
bsdb:230/1/2_Food-allergy:infant-with-food-allergy_vs_non-allergy_UP	NA	1485
bsdb:231/1/1_Diet:Renatta-canada-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	35832	119852	375288	1263	86331
bsdb:231/1/2_Diet:Renatta-canada-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_UP	NA	1678
bsdb:232/1/1_HIV-infection:HIV-infected-cART-negative_vs_Healthy-controls_UP	NA	165779	848	1257	836
bsdb:232/1/2_HIV-infection:HIV-infected-cART-negative_vs_Healthy-controls_DOWN	NA	239759	33042	1730	28050	841	1263
bsdb:233/1/1_HIV-infection:HIV-infected-subjects_vs_uninfected-controls_UP	NA	469	838
bsdb:233/1/2_HIV-infection:HIV-infected-subjects_vs_uninfected-controls_DOWN	NA	816	572511	33042
bsdb:237/1/1_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_UP	NA	239934	1283313	544	724	1578	1269	1253	1301	29465	46255	1485
bsdb:237/1/2_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_DOWN	NA	35829	35832	574697	52225	1017280	213484	172900
bsdb:238/1/1_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	40544	1505663	437755	946234	459786	1301
bsdb:238/1/2_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	239759	207244	816	572511	547	561	1407607	1505657	375288	1501226	620	574697
bsdb:242/1/1_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	475	1357	286	1350	57493	1578
bsdb:242/1/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	1716	482	416916	2717
bsdb:243/1/1_Gastric-cancer:current-H.pylori-infection_vs_non-current-H.pylori-infection_UP	NA	1378
bsdb:243/1/2_Gastric-cancer:current-H.pylori-infection_vs_non-current-H.pylori-infection_DOWN	NA	12916	1827
bsdb:244/1/1_Age:18-62-years_vs_2-12-years_UP	NA	1743	1716	1279	1578	150022	165779
bsdb:244/1/2_Age:18-62-years_vs_2-12-years_DOWN	NA	32207	1301	117563	1378	724
bsdb:245/1/1_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_UP	NA	469	1283313	85413	561	1730	1573534	1506553	158846	620
bsdb:245/1/2_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	1508657	39948	61170	168934	638847	1678	841	577310	547
bsdb:246/1/1_Asthma:maternal-asthma/male-caucasian-infants_vs_no-asthma_UP	NA	1654	1357	158846
bsdb:246/1/2_Asthma:maternal-asthma/male-caucasian-infants_vs_no-asthma_DOWN	NA	158851	1578
bsdb:247/1/1_Diet:Placebo_vs_Prebiotic_UP	NA	33042	189330	119852
bsdb:247/1/2_Diet:Placebo_vs_Prebiotic_DOWN	NA	1678
bsdb:249/1/1_Hepatitis,-Alcoholic:alcoholics_vs_NAC_UP	NA	374	33882	1843210	1716
bsdb:249/1/2_Hepatitis,-Alcoholic:alcoholics_vs_NAC_DOWN	NA	2053	1839	53387	1678	816	397864	577309	838	239759	237	182709	94008	572511	1263	186650	265	780	114248	12916	47420	215579	29580	70774	642
bsdb:251/1/1_Milk-allergic-reaction:cow’s-milk-allergic-(CMA)-infants-colonized-mice_vs_healthy-Infants-colonised-mice_UP	NA	572511	100883	1350	375288	1263
bsdb:251/1/2_Milk-allergic-reaction:cow’s-milk-allergic-(CMA)-infants-colonized-mice_vs_healthy-Infants-colonised-mice_DOWN	NA	590	1301
bsdb:254/1/1_Nephrolithiasis,Urolithiasis:kidney-stone-patient_vs_healthy-control_UP	NA	239759	816	375288
bsdb:254/1/2_Nephrolithiasis,Urolithiasis:kidney-stone-patient_vs_healthy-control_DOWN	NA	150022	162289	838	184869
bsdb:256/1/1_Gastric-cancer:peritumoral-tissues_vs_normal-tissues_UP	NA	45402	2745	209	1578	407	1257	970	22	1301	29465
bsdb:256/1/2_Gastric-cancer:peritumoral-tissues_vs_normal-tissues_DOWN	NA	1386	816	1716	216851	848	33024	838	1743	286	13687
bsdb:257/1/1_Colorectal-cancer:colorectal-cancer_vs_healthy-control_UP	NA	239934	35832	574697	990721	1485	51514	848	283168	119852	846	375288	1257	836	1263	970	1730
bsdb:257/1/2_Colorectal-cancer:colorectal-cancer_vs_healthy-control_DOWN	NA	158846	52225
bsdb:258/1/1_Colorectal-cancer:carcinoma_vs_Healthy-Controls_UP	NA	848	836	1485
bsdb:258/1/2_Colorectal-cancer:carcinoma_vs_Healthy-Controls_DOWN	NA	816	1279	1485
bsdb:260/1/2_Food-allergy:Allergic-Estonian-children._vs_Nonallergic--Estonian-children._DOWN	NA	1678	1578
bsdb:262/1/1_Atopic-asthma:nasal-brush-speciments_vs_bronchial-brush-specimens_UP	NA	1651	1716	475	1279
bsdb:262/1/2_Atopic-asthma:nasal-brush-speciments_vs_bronchial-brush-specimens_DOWN	NA	1654	32067	836	838	1301
bsdb:264/1/1_Human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_UP	NA	28263	39948	906	162289	1257	838	168808
bsdb:264/1/2_Human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_DOWN	NA	56688	1578
bsdb:265/1/1_Human-papilloma-virus-infection,Age:two-months_vs_at-birth_UP	NA	32207	1301	29465	724	150022
bsdb:265/1/2_Human-papilloma-virus-infection,Age:two-months_vs_at-birth_DOWN	NA	357	816	80865	1578	906	1743	286	1279
bsdb:266/1/1_Diet:Healthy-vegetarian_vs_Healthy-non-vegetarian_UP	NA	1301	838	570	216851	841	572511
bsdb:266/1/2_Diet:Healthy-vegetarian_vs_Healthy-non-vegetarian_DOWN	NA	239934	239759	816	1678	1485	33042	39948	158846	459786	375288	33024	590
bsdb:268/1/1_Cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_UP	NA	1485	102106	1716	168808	29465
bsdb:268/1/2_Cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_DOWN	NA	1279	48736
bsdb:269/1/1_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	816
bsdb:269/1/2_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	194	1716	1678	1380	162289	1279	838	165779	836
bsdb:269/1/3_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	1678
bsdb:269/1/4_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	1380	816	838	848	1716
bsdb:270/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808	906	1253	1696	286
bsdb:270/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	83618	1654	213484	222991
bsdb:274/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	838
bsdb:274/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1654	1678	39948	2701	1578
bsdb:275/1/1_Acute-lymphoblastic-leukemia:adolescent-ALL-patient_vs_healthy-sibling-control_UP	NA	816
bsdb:275/1/2_Acute-lymphoblastic-leukemia:adolescent-ALL-patient_vs_healthy-sibling-control_DOWN	NA	841
bsdb:277/1/1_Crohn's-disease:crohn's-disease_vs_healthy-control_DOWN	NA	216851	1263	841	239759	1730	46239	206664	836	28138	375288	830
bsdb:278/1/1_Non-alcoholic-fatty-liver-disease:NAFLD--[non-alcoholic-fatty-liver-disease]_vs_Healthy-control_UP	NA	1578
bsdb:278/1/2_Non-alcoholic-fatty-liver-disease:NAFLD--[non-alcoholic-fatty-liver-disease]_vs_Healthy-control_DOWN	NA	239759	207244	816	572511	189330	216851	33042	841	375288
bsdb:282/1/2_Graft-versus-host-disease:Grades-II-IV-(acute-graft-host-disease)_vs_Grades-0-I-(non-acute-graft-host-disease)_DOWN	NA	1506553	572511
bsdb:283/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	84111	1378
bsdb:284/1/1_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	1654	59735	1716	32207	1301	1578
bsdb:284/1/2_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_DOWN	NA	848	836
bsdb:285/1/1_Multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_UP	NA	35832	1678	872	135858	33024
bsdb:285/1/2_Multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_DOWN	NA	28050	577309	816	119852
bsdb:286/1/2_Graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_DOWN	NA	207244	572511	574697	102106	1407607	1263
bsdb:288/1/1_Phenylketonuria:phenylketonuric-with-Phe-restricted-diet_vs_mild-hyperphenylalaninemic-with-unrestricted-diet_DOWN	NA	841	1578
bsdb:289/1/1_Health-trait:suboptimal-health-status_vs_healthy-controls_UP	NA	59732	119852	841	1263
bsdb:289/1/2_Health-trait:suboptimal-health-status_vs_healthy-controls_DOWN	NA	581	48736	40544
bsdb:291/1/1_Graves-disease:graves-disease_vs_healthy-controls_UP	NA	838	724
bsdb:291/1/2_Graves-disease:graves-disease_vs_healthy-controls_DOWN	NA	239759	216851	39948
bsdb:295/1/1_Human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_UP	NA	1654	239759	1678	35832	572511	574697	1485	1348911	33042	39948	1407607	204475	70774	906	745	1257	33024	841	1263	1200657	168808	40544
bsdb:295/1/2_Human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_DOWN	NA	209	68	497726
bsdb:301/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	39948	906	168808	848
bsdb:301/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1578
bsdb:303/1/1_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	544	1350	375288	1380	570
bsdb:303/1/2_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	447020	165779	1380	1678	572511	1485	102106	33042	189330	570	28050	119852	841	1263
bsdb:304/1/1_Antimicrobial-agent:oral-intake-of-vancomycin-(directed-against-Gram-positive-bacteria)_vs_or-placebo-(microcrystalline-cellulose)_UP	NA	1380	1678	102106
bsdb:305/1/1_Genital-neoplasm,-female:women-with-gynecological-cancer_vs_healthy-controls_UP	NA	165779	39948	1582879	848	2050	437755	2093	543311	162289	1257	836	838	168808
bsdb:305/1/2_Genital-neoplasm,-female:women-with-gynecological-cancer_vs_healthy-controls_DOWN	NA	1678	1578	177971
bsdb:309/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	816	574697	1578	375288	59195
bsdb:310/1/1_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	816	561
bsdb:310/1/2_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	572511	216851	841	1678
bsdb:313/1/1_Non-Hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_UP	NA	29465
bsdb:313/1/2_Non-Hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_DOWN	NA	574697	51514	216851	119852	40544
bsdb:314/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	1380	168808	906	543311	838
bsdb:314/1/2_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_DOWN	NA	1578
bsdb:319/1/1_Air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_UP	NA	248744	2093
bsdb:319/1/2_Air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_DOWN	NA	209	1501226	100175	174708	191303
bsdb:321/1/1_Antimicrobial-agent:10-d-old-7-10-day-treatment-infants_vs_10-d-old-2-day-treatment-infants_DOWN	NA	816	1357
bsdb:323/1/1_Necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1485	1279
bsdb:323/1/2_Necrotizing-enterocolitis:NEC_vs_non-NEC_DOWN	NA	28196	150022	29330	1654	286	59732	283	1301	1716
bsdb:324/1/1_Thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_UP	NA	207244	33042	561	1505657	570	1578	620	1301	292632	191303	1357	239759
bsdb:324/1/2_Thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_DOWN	NA	1283313	816	1506553	158846	33024	838	841
bsdb:326/1/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders-(partial-response-or-stable-disease)_vs_Non-Responders-(progression-or-death)_UP	NA	239759	816	1392389	838
bsdb:326/1/2_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders-(partial-response-or-stable-disease)_vs_Non-Responders-(progression-or-death)_DOWN	NA	572511	838
bsdb:327/1/1_Antimicrobial-agent:infants-who-received-short-term-or-long-term-antibiotic-treatment---week-1_vs_control-(no-treatment)---week-1_UP	NA	1578
bsdb:327/1/2_Antimicrobial-agent:infants-who-received-short-term-or-long-term-antibiotic-treatment---week-1_vs_control-(no-treatment)---week-1_DOWN	NA	561	1301
bsdb:329/1/1_Antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/1/2_Antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:330/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	2129
bsdb:331/1/1_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	207244	572511	580596	33042	189330	1407607	724	1501226	841	1301	292632	1485
bsdb:331/1/2_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_DOWN	NA	816	216851	838	1283313	33024	1506553	375288	577309	1154586
bsdb:334/1/1_Antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_UP	NA	1618113
bsdb:334/1/2_Antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_DOWN	NA	1678
bsdb:336/1/1_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_Antibiotic-free-group-(postnatal-day-3)_UP	NA	816	1578	13687
bsdb:336/1/2_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_Antibiotic-free-group-(postnatal-day-3)_DOWN	NA	1485
bsdb:337/1/1_Antimicrobial-agent:3-month-old-infants-exposed-to-antibiotics-in-the-second-trimester_vs_3-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	1407607	1350
bsdb:337/1/2_Antimicrobial-agent:3-month-old-infants-exposed-to-antibiotics-in-the-second-trimester_vs_3-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	816	1279	1301	29465
bsdb:338/1/1_Obesity:obese-children_vs_normal-weight-children_UP	NA	216851	724	28050	158846	33024
bsdb:338/1/2_Obesity:obese-children_vs_normal-weight-children_DOWN	NA	39948	119852
bsdb:340/1/1_Inflammatory-bowel-disease:Pouchitis_vs_Normal-pouch_UP	NA	469	10	629	100883	561	586	84108	29465
bsdb:340/1/2_Inflammatory-bowel-disease:Pouchitis_vs_Normal-pouch_DOWN	NA	773	189330	2745	1253
bsdb:341/1/1_Smoking-behavior:patients-with-FD,-ID,or-CD-who-currently-smoked_vs_never-smoked_UP	NA	32207	1301	29465
bsdb:342/1/1_Asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-asthma-exacerbation_DOWN	NA	724
bsdb:343/1/1_Leukemia:Acute-anti-leukemia-treatment_vs_Allogeneic-Hematopoetic-Stem-Cell-Transplant_UP	NA	816	239934	216851
bsdb:343/1/2_Leukemia:Acute-anti-leukemia-treatment_vs_Allogeneic-Hematopoetic-Stem-Cell-Transplant_DOWN	NA	1485
bsdb:345/1/1_Response-to-diet:Female-hamsters-Low-protein-diet-(LPD)-group_vs_Female-hamsters-Normal-protein-diet-(NPD)-group_UP	NA	2086	816	156973	690621
bsdb:345/1/2_Response-to-diet:Female-hamsters-Low-protein-diet-(LPD)-group_vs_Female-hamsters-Normal-protein-diet-(NPD)-group_DOWN	NA	469	174708	308865	204475	1159323	264147	248038	2093	217063	119852	146	577309
bsdb:350/1/1_Obesity:Obese-children-(O)_vs_Normal-weight-(NW)_UP	NA	836
bsdb:350/1/2_Obesity:Obese-children-(O)_vs_Normal-weight-(NW)_DOWN	NA	33024
bsdb:354/1/2_Obesity:overweight/obese_vs_control-(BMI-at-normal-range)_DOWN	NA	872
bsdb:357/1/1_Air-pollution:post-smog-swabs_vs_pre-smog-swabs_UP	NA	32067
bsdb:357/1/2_Air-pollution:post-smog-swabs_vs_pre-smog-swabs_DOWN	NA	838
bsdb:360/1/1_Air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_UP	NA	191303	1485
bsdb:360/1/2_Air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_DOWN	NA	1578	119852
bsdb:365/1/1_Methionine-measurement:mice-fed-American-Diet_vs_mice-fed-control-rodent-diet._UP	NA	33042	119852	1263	1386	1357
bsdb:365/1/2_Methionine-measurement:mice-fed-American-Diet_vs_mice-fed-control-rodent-diet._DOWN	NA	1485	838
bsdb:369/1/1_Obesity:obese_vs_normal-weight_UP	NA	816	28050	841
bsdb:369/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	84108	838	119852
bsdb:372/1/1_Air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_UP	NA	1578
bsdb:372/1/2_Air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_DOWN	NA	816	1485
bsdb:373/1/1_Obesity:overweight-children_vs_normal-weight-children_UP	NA	33042
bsdb:373/1/2_Obesity:overweight-children_vs_normal-weight-children_DOWN	NA	239759
bsdb:374/1/1_Cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-controls_UP	NA	114627	1643951	953
bsdb:374/1/2_Cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-controls_DOWN	NA	53246	497
bsdb:379/1/1_Obesity:non-obese_vs_obese_UP	NA	1678	1578
bsdb:382/1/1_Chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_UP	NA	1375
bsdb:382/1/2_Chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_DOWN	NA	1578
bsdb:385/1/1_Gastric-adenocarcinoma:Gastric-adenocarcinoma-(GC)_vs_Superficial-gastritis-(SG)_UP	NA	416916	1283313	482	836
bsdb:385/1/2_Gastric-adenocarcinoma:Gastric-adenocarcinoma-(GC)_vs_Superficial-gastritis-(SG)_DOWN	NA	1654	1380	150203	561	165695
bsdb:386/1/1_Pulmonary-tuberculosis:Tuberculosis-(TB)-patients_vs_healthy-controls_UP	NA	33042
bsdb:391/1/1_Neuromyelitis-optica:neuromyelitis-optica-spectrum-disorder_vs_healthy-controls_UP	NA	561	620	265975	1486725	156454	946234	1301
bsdb:391/1/2_Neuromyelitis-optica:neuromyelitis-optica-spectrum-disorder_vs_healthy-controls_DOWN	NA	40544	1407607	33042	1501226	572511	841	216851	838
bsdb:392/1/1_Milk-allergic-reaction:non-IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	239759	816	1266
bsdb:393/1/1_Milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-tolerant-to-cow's-milk-protein_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-non-tolerant-to-cow's-milk-protein_UP	NA	1678
bsdb:394/1/1_Asthma:child-with-asthma-at-age-6_vs_healthy-control_UP	NA	838	29465
bsdb:396/1/1_Atopic-eczema:atopic-dermatitis_vs_healthy-control_UP	NA	1279
bsdb:396/1/2_Atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	47670	106589
bsdb:398/1/1_Atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	1279
bsdb:399/1/1_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	32207	1301	29465	1578	1678
bsdb:399/1/2_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	1016	848	724	482	195950	157	538	47670	43994	2717	283	44259	1743	1716	836	1481960
bsdb:400/1/1_Asthma:asthma_vs_healthy-control_UP	NA	1485	1350	561	1730	1578
bsdb:400/1/2_Asthma:asthma_vs_healthy-control_DOWN	NA	39948	216851	841
bsdb:401/1/1_Asthma:asthma_vs_healthy-control_UP	NA	970
bsdb:401/1/2_Asthma:asthma_vs_healthy-control_DOWN	NA	830	543311
bsdb:403/1/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	841	551
bsdb:403/1/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	547
bsdb:405/1/1_Asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_UP	NA	29465	1301
bsdb:405/1/2_Asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_DOWN	NA	841	239759	946234	216851	1678	572511	375288	207244	1263	39948	838
bsdb:407/1/1_Peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_UP	NA	1380	1730	1164882	906	265975	1257	838	123375	29465	356797
bsdb:407/1/2_Peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_DOWN	NA	416916	194	1716	538	44259	2701	1378	940557	52228	43994	1508421	482	113286	32207	1301	157	843
bsdb:410/1/1_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_UP	NA	165779	194	150022	162289
bsdb:410/1/2_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_DOWN	NA	838
bsdb:411/1/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	1301	848	52225
bsdb:411/1/2_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_DOWN	NA	561	620
bsdb:412/1/1_HIV-infection,Methamphetamine-dependence:HIV-positive-MA-users_vs_HIV-positive-non-MA-users_UP	NA	1654	75984	909928	34104
bsdb:415/1/1_HIV-infection:HIV-positive-women-who-have-been-taking-ART-for-more-than-1-year_vs_Age-matched-HIV-uninfected-women_UP	NA	265975	437755
bsdb:417/1/1_HIV-infection,Diabetes-mellitus:Women-with-diabetes_vs_Women-without-diabetes_DOWN	NA	165779	150022	168808	447020
bsdb:418/1/1_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	872	158846
bsdb:418/1/2_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:419/1/1_HIV-infection:combination-antiretroviral-therapy-treated-individuals-after-taking-LGG-probiotic-for-8-weeks_vs_baseline_UP	NA	1508657
bsdb:420/1/1_HIV-infection:Probiotic-group-after-8-weeks-of-intervention_vs_baseline-probiotic-group_UP	NA	1678
bsdb:420/1/2_HIV-infection:Probiotic-group-after-8-weeks-of-intervention_vs_baseline-probiotic-group_DOWN	NA	816
bsdb:422/1/1_HIV-infection:Perinatally-HIV-infected-children_vs_uninfected-age-matched-controls_UP	NA	838	906	970	1485	32067	53335
bsdb:422/1/2_HIV-infection:Perinatally-HIV-infected-children_vs_uninfected-age-matched-controls_DOWN	NA	816	51514	216851	724	475961	48463	1263
bsdb:423/1/2_Amyotrophic-lateral-sclerosis:Amyotrophic-lateral-sclerosis---ALS-patients_vs_Healthy-controls_DOWN	NA	158846
bsdb:424/1/1_Pancreatic-carcinoma:Pancreatic-cancer-patients_vs_Healthy-control_UP	NA	239934	906	283168
bsdb:424/1/2_Pancreatic-carcinoma:Pancreatic-cancer-patients_vs_Healthy-control_DOWN	NA	207244	216851	292632
bsdb:956/1/1_Schizophrenia:Schizophrenia-patients-with-prominent-negative-symptoms-(SCH-N)_vs_Healthy-controls_UP	NA	222	100883	1573534	848	1506553	1960084	1266	1279
bsdb:956/1/2_Schizophrenia:Schizophrenia-patients-with-prominent-negative-symptoms-(SCH-N)_vs_Healthy-controls_DOWN	NA	1766253	507	580596	102106	33042	39948	189330	216851	52225	2039302	1263
bsdb:1032/1/1_Hepatocellular-carcinoma:Patients-with-Hepatocellular-carcinoma-(HCC)_vs_Healthy-controls_UP	NA	816	1301	29465	3025755
bsdb:1032/1/2_Hepatocellular-carcinoma:Patients-with-Hepatocellular-carcinoma-(HCC)_vs_Healthy-controls_DOWN	NA	1501226	35832
bsdb:1033/1/1_Papillary-thyroid-carcinoma:PTC-patients-with-advanced-lesions-(T3_4)_vs_PTC-patients-with-mild-lesions-(T1_2)_UP	NA	1301	117563	724
bsdb:1033/1/2_Papillary-thyroid-carcinoma:PTC-patients-with-advanced-lesions-(T3_4)_vs_PTC-patients-with-mild-lesions-(T1_2)_DOWN	NA	286	1827	13687
bsdb:1034/1/1_Birth-measurement:High-vaginal-sialidase-activity_vs_Low-vaginal-sialidase-activity_UP	NA	1375	1380	1485	39948	2701	1378	906	543311	838
bsdb:1034/1/2_Birth-measurement:High-vaginal-sialidase-activity_vs_Low-vaginal-sialidase-activity_DOWN	NA	32008	80865	963	1578	1007	504481
bsdb:1035/1/1_Urinary-schistosomiasis:Infection-Only_vs_Healthy-Control_UP	NA	469	1375	59732	66831	570	286	22	1279
bsdb:1035/1/2_Urinary-schistosomiasis:Infection-Only_vs_Healthy-Control_DOWN	NA	469	635	547	551	2701	568	131079	13159	29487	497	46255	1279
bsdb:1036/1/1_Behcet's-syndrome:Behcet's-disease-recipient-mice_vs_Healthy-controls-recipient-mice_UP	NA	1357	35832	33042	283	283168	580024	33024	42255	1432051	2129	149698	209879
bsdb:1036/1/2_Behcet's-syndrome:Behcet's-disease-recipient-mice_vs_Healthy-controls-recipient-mice_DOWN	NA	133925	1386	239934	1283313
bsdb:1037/1/1_Chronic-constipation:Constipated-women_vs_Healthy-women_UP	NA	816	1407607	375288	544
bsdb:1037/1/2_Chronic-constipation:Constipated-women_vs_Healthy-women_DOWN	NA	570	841
bsdb:1038/1/1_Response-to-radiation:Premenopausal-Pre-treatment-group_vs_Premenopausal-healthy-controls-(HPV-Negative-women)_UP	NA	165779	1380	118747	194	39948	236752	1686313	848	1378	2050	437755	543311	2740	162289	1257	836	838	123375	1213720
bsdb:1038/1/2_Response-to-radiation:Premenopausal-Pre-treatment-group_vs_Premenopausal-healthy-controls-(HPV-Negative-women)_DOWN	NA	469	31988	1912216	1578	286	67575	1279
bsdb:1039/1/1_Diet:Urban-Xhosa-Cohort_vs_Rural-Xhosa-Cohort_UP	NA	816	33024	848	830	1506553	3025755	239759	35832	946234	283168	397864	459786	1432051	1980693
bsdb:1039/1/2_Diet:Urban-Xhosa-Cohort_vs_Rural-Xhosa-Cohort_DOWN	NA	265975	1470353	423604	970	157	39948	216851	838
bsdb:1040/1/1_COVID-19:RPs-(Recovered-Patients)_vs_HCs-(Healthy-Controls)_UP	NA	28196	36922	44249	5094	270	46255	43994	265975	1213720	118747	29465	848	168808	69278	34019	528	57739	475
bsdb:1040/1/2_COVID-19:RPs-(Recovered-Patients)_vs_HCs-(Healthy-Controls)_DOWN	NA	5475	2801844	1283313	838	308865	59734	2737	407	68287	374	953	1381133	47670	48736	416916	662
bsdb:1041/1/1_Oral-cavity-carcinoma:Tumor-tissue-(TT)-samples_vs_Adjacent-normal-tissue-(AT)_UP	NA	41275
bsdb:1041/1/2_Oral-cavity-carcinoma:Tumor-tissue-(TT)-samples_vs_Adjacent-normal-tissue-(AT)_DOWN	NA	482	528	508215	29465
bsdb:1042/1/1_Insecticide:permethrin-resistant-mosquito_vs_permethrin-susceptible-mosquito_UP	NA	28453	400634	1301	42255
bsdb:1042/1/2_Insecticide:permethrin-resistant-mosquito_vs_permethrin-susceptible-mosquito_DOWN	NA	32
bsdb:1043/1/1_Human-immunodeficiency-virus:Acute-HIV-infected-participants-at-baseline-(A0)_vs_HIV-uninfected-MSM----controls-(D)_UP	NA	838
bsdb:1043/1/2_Human-immunodeficiency-virus:Acute-HIV-infected-participants-at-baseline-(A0)_vs_HIV-uninfected-MSM----controls-(D)_DOWN	NA	32067	1578	32207	47670	195950	1716	191303	841	1501226	816	82202	459786	475	43996
bsdb:1050/1/1_Taxonomic-microbiome-measurement:Esophagus_vs_Oral-cavity_UP	NA	469	713	174708	572511	374	59732	33042	212791	407	165696	528	119852	20	1743	286	48736	1007	504481	165695	13687	1279	40323	1301
bsdb:1050/1/2_Taxonomic-microbiome-measurement:Esophagus_vs_Oral-cavity_DOWN	NA	1654	2717	482	346096	970
bsdb:1072/1/1_Non-alcoholic-fatty-liver-disease:HIV+-MASLD+_vs_HIV--MASLD+_UP	NA	189330	1506577	86331	123375	1501226	1485	2740	2172	248744	1573535	572511	1506553
bsdb:1072/1/2_Non-alcoholic-fatty-liver-disease:HIV+-MASLD+_vs_HIV--MASLD+_DOWN	NA	1508657	1350	53335	629	1578	1263	1301	1766253	841	239759	292632	46255	207244
bsdb:1079/1/1_Esophageal-adenocarcinoma:Cluster-2_vs_Cluster-1_UP	NA	836	838	1301
bsdb:1079/1/2_Esophageal-adenocarcinoma:Cluster-2_vs_Cluster-1_DOWN	NA	838
bsdb:1080/1/1_Lower-respiratory-tract-disease:Chronic-Otitis-Media-With-Effusion-(COME)-with-asthma-or-bronchiolitis_vs_Chronic-Otitis-Media-With-Effusion-(COME)-without-asthma-or-bronchiolitis_UP	NA	724	1279	475
bsdb:1081/1/1_Taxonomic-microbiome-measurement:Highly-attractive-group_vs_Poorly-attractive-group_UP	NA	73778	13687	1279
bsdb:1081/1/2_Taxonomic-microbiome-measurement:Highly-attractive-group_vs_Poorly-attractive-group_DOWN	NA	41275	1716	665874
bsdb:1082/1/2_Polycystic-ovary-syndrome:polycystic-ovary-syndrome-(PCOS)-like-mice_vs_Controls_DOWN	NA	816	375288	1647175
bsdb:1083/1/1_Age:B-Group-(B25.2)_vs_B-Group-(B15.2)_UP	NA	1234
bsdb:1085/1/1_Gut-microbiome-measurement:High-Bifidobacterium-group_vs_Low-Bifidobacterium-group_UP	NA	1678	1716	1301
bsdb:1085/1/2_Gut-microbiome-measurement:High-Bifidobacterium-group_vs_Low-Bifidobacterium-group_DOWN	NA	1279	1350	570	1485
bsdb:1086/1/1_Phenylketonuria:Phenylketonuria-(PKU-S)_vs_Control-(CTRL-S)_UP	NA	194	724	1164882	29465
bsdb:1086/1/2_Phenylketonuria:Phenylketonuria-(PKU-S)_vs_Control-(CTRL-S)_DOWN	NA	1654	2801844	2717	43996	1434006	133925	2740	1257	1213720
bsdb:1088/1/1_Schizophrenia:SCZF:-patients-with-schizophrenia_vs_HCF:-healthy-controls-(no-psychiatric-diagnosis-of-schizophrenia)_UP	NA	1654	1663	102106	106589	1730	88	13159	354349	286	113286	620
bsdb:1088/1/2_Schizophrenia:SCZF:-patients-with-schizophrenia_vs_HCF:-healthy-controls-(no-psychiatric-diagnosis-of-schizophrenia)_DOWN	NA	447020	239759	92793	816	33042	1350	216851	724	1159323	119852	375288	838	46205	1263
bsdb:1089/1/1_Treatment:Schizophrenia-patients-after-treatment-(AT)_vs_Schizophrenia-patients-before-treatment-(BT)_UP	NA	580596	216851	119852	838	841	458032
bsdb:1089/1/2_Treatment:Schizophrenia-patients-after-treatment-(AT)_vs_Schizophrenia-patients-before-treatment-(BT)_DOWN	NA	32207
bsdb:1090/1/1_Metabolic-syndrome:Schizophrenia-patients-without-MetS_vs_Schizophrenia-patients-with-MetS_UP	NA	239934	135858	1485	1730	1266	191303	1218
bsdb:1090/1/2_Metabolic-syndrome:Schizophrenia-patients-without-MetS_vs_Schizophrenia-patients-with-MetS_DOWN	NA	816	32008	1485	39948	1578	158846	375288	40544
bsdb:1091/1/1_Chronic-gastritis,Gastric-cancer:Gastric-Cancer_vs_Chronic-gastritis_UP	NA	33042	848	724	1578	459786	375288	33024	40544	29465
bsdb:1091/1/2_Chronic-gastritis,Gastric-cancer:Gastric-Cancer_vs_Chronic-gastritis_DOWN	NA	469	447020	1678	102106	1350	1730	581	286
bsdb:1092/1/1_Cognitive-decline-measurement:Probiotic-group_vs_Placebo-group_UP	NA	838
bsdb:1092/1/2_Cognitive-decline-measurement:Probiotic-group_vs_Placebo-group_UP	NA	577310	816	838
bsdb:1093/1/1_Schizophrenia:SCZ:-individuals-with-a-psychiatric-diagnosis-of-schizophrenia_vs_HC:-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_UP	NA	816	1380	848	906	29465	239934
bsdb:1093/1/2_Schizophrenia:SCZ:-individuals-with-a-psychiatric-diagnosis-of-schizophrenia_vs_HC:-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_DOWN	NA	816	33024	397864	572511	33042	39948	1407607	570	407	1301
bsdb:1094/1/1_Schizophrenia:SZ:-patients-with-schizophrenia_vs_NC:-normal-controls_UP	NA	904	119977	244127	118747	135858	1485	102106	33870	1716	872	547	1378	1578	52225	86331	583	1266	970	83770	28033	179
bsdb:1094/1/2_Schizophrenia:SZ:-patients-with-schizophrenia_vs_NC:-normal-controls_DOWN	NA	239934	580596	508459	189330	216851	1357	906	482	638847	29465
bsdb:1095/1/1_Metabolite:HF+DI-(High-fat-and-Dimethyl-Itaconate-treated-mice)_vs_HF+Veh-(High-fat-and-Vehicle-treated-mice)_UP	NA	174708	1283313	191	83770
bsdb:1095/1/2_Metabolite:HF+DI-(High-fat-and-Dimethyl-Itaconate-treated-mice)_vs_HF+Veh-(High-fat-and-Vehicle-treated-mice)_DOWN	NA	1392389	1506553	83618	1508657	332162
bsdb:1096/1/1_Gut-microbiome-measurement:Infants_vs_Mothers_UP	NA	258514	447020	239759	244127	109326	397864	572511	580596	1348911	33042	39948	216851	1407607	204475	644652	61170	1392389	86331	459786	841	1263
bsdb:1096/1/2_Gut-microbiome-measurement:Infants_vs_Mothers_DOWN	NA	1654	1380	1678	84111	547	1350	150022	1378	117563	570	1578	68287	32207	13687	1279	29465
bsdb:1099/1/1_Schizophrenia:SCH-patients_vs_healthy-controls_DOWN	NA	1501226
bsdb:1099/1/2_Schizophrenia:SCH-patients_vs_healthy-controls_UP	NA	1506553
bsdb:1100/1/1_Autism-spectrum-disorder:Autistic_vs_Healthy-controls_UP	NA	816	158846	838
bsdb:1100/1/2_Autism-spectrum-disorder:Autistic_vs_Healthy-controls_DOWN	NA	1432051
bsdb:1103/1/1_Dry-eye-syndrome:Mild-Dry-Eye_vs_control_UP	NA	1663	748770	57494	13687	1569
bsdb:1103/1/2_Dry-eye-syndrome:Mild-Dry-Eye_vs_control_DOWN	NA	1578	1716	212791	528	1743
bsdb:1104/1/1_Gut-microbiome-measurement:Paternal-Gut-Microbiome-Depleted-Mice_vs_Male-Mice-with-Normal-Gut-Microbiome_DOWN	NA	816	1578	1485
bsdb:1104/1/2_Gut-microbiome-measurement:Paternal-Gut-Microbiome-Depleted-Mice_vs_Male-Mice-with-Normal-Gut-Microbiome_UP	NA	816	1578
bsdb:1106/1/1_Breastfeeding-duration:Non_Exclusive-Breast-Feeding-(Non-EBF)_vs_Exclusive-Breast-Feeding-(EBF)_UP	NA	1678	1350
bsdb:1106/1/2_Breastfeeding-duration:Non_Exclusive-Breast-Feeding-(Non-EBF)_vs_Exclusive-Breast-Feeding-(EBF)_DOWN	NA	1578	838	572511	102106	135858
bsdb:1108/1/1_HIV-infection,Abnormal-inflammatory-response:HIV-infected_vs_HIV-uninfected_UP	NA	84108	102106
bsdb:1108/1/2_HIV-infection,Abnormal-inflammatory-response:HIV-infected_vs_HIV-uninfected_DOWN	NA	1501226
bsdb:1111/1/1_Relapsing-remitting-multiple-sclerosis:Caucasian-Americans-(CA)_vs_Healthy-Controls_UP	NA	1485	239934
bsdb:1114/1/1_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_UP	NA	191303	142587
bsdb:1114/1/2_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_DOWN	NA	253238	906	838	32207	292632	29465
bsdb:1115/1/1_Ischemic-stroke:Patients-with-stroke-associated-pneumonia-(SAP)_vs_Patients-without-stroke-associated-pneumonia-(non-SAP)_UP	NA	830	1716
bsdb:1115/1/2_Ischemic-stroke:Patients-with-stroke-associated-pneumonia-(SAP)_vs_Patients-without-stroke-associated-pneumonia-(non-SAP)_DOWN	NA	580596	1407607
bsdb:1117/1/1_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_UP	NA	1654	978	279	2985502
bsdb:1117/1/2_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_DOWN	NA	1375	212791	216851	963	497	93681
bsdb:1118/1/1_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_UP	NA	46123	547	848	1506553	906	1827	1301	29465
bsdb:1118/1/2_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_DOWN	NA	239759	207244	816	397864	1678	216851	1407607	119852	577309	577310	841	292632	172900
bsdb:1118/1/3_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_DOWN	NA	216851	239759	1678	841
bsdb:1121/1/1_Vaginal-microbiome-measurement:Published-DNA_vs_Experimental-DNA-(AC)_UP	NA	165779	1380	2701	1578	906	838	168808
bsdb:1121/1/2_Vaginal-microbiome-measurement:Published-DNA_vs_Experimental-DNA-(AC)_DOWN	NA	2701	838
bsdb:1124/1/2_Vaginal-microbiome-measurement:Women-with-varying-vaginal-microbiome-profiles-based-on-their-ancestry._vs_Women-without-any-specific-microbiome-conditions_DOWN	NA	1279
bsdb:1125/1/2_Gut-microbiome-measurement,Glucose-metabolism-measurement:African-citizens_vs_Han-Chinese_DOWN	NA	816
bsdb:1130/1/1_Diarrhea:Diarrhea_vs_healthy-controls_UP	NA	1301
bsdb:1139/1/1_Gut-microbiome-measurement:Prebiotic-group_vs_Placebo-group_DOWN	NA	1678	1924093	1730
bsdb:1141/1/1_Postnatal-growth-retardation:Colostrum-deprived-mice_vs_Control_UP	NA	248744	1331051
bsdb:1141/1/2_Postnatal-growth-retardation:Colostrum-deprived-mice_vs_Control_DOWN	NA	1506577
bsdb:1142/1/1_Hypertrophy:Tonsillar-hypertrophy-(TH)_vs_Control_UP	NA	1678	39948	308865	44259	1378	1578	543311	2171988
bsdb:1144/1/1_Autism-spectrum-disorder:Children-with-Autism-Spectrum-Disorder-(ASD)_vs_Healthy-children_UP	NA	216851	838	292632	1263	1766253
bsdb:1144/1/2_Autism-spectrum-disorder:Children-with-Autism-Spectrum-Disorder-(ASD)_vs_Healthy-children_DOWN	NA	1678	1730
